Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.


A new report from ProPublica and the New York Times about insurers and opioid addiction reveals insurance providers prioritize drug costs over addiction risks. (Photo: frankieleon/Flickr/cc)

Bolstering Single-Payer Case, Report Shows How For-Profit Insurers Fuel Opioid Crisis

"In case you didn't know, the opioid epidemic is fueled in part by systemic failures in healthcare."

Jessica Corbett

Showcasing yet another downside of the nation's for-profit system, a new report by ProPublica and the New York Times reveals that despite the U.S. opioid crisis, many insurance companies provide easy access to highly addictive opioid medications for pain relief while restricting access to less-risky but more costly alternatives.

As the nation's opioid epidemic has grown, "drugmakers, pharmaceutical distributors, pharmacies, and doctors have come under intense scrutiny in recent years, but the role that insurers—and the pharmacy benefit managers that run their drug plans—have played in the opioid crisis has received less attention," note the Times' Katie Thomas and ProPublica's Charles Ornstein.

The pair spoke with patients who have struggled to access pain relief medications through insurance providers such as Anthem and UnitedHealthcare, the nation's largest insurer. They also analyzed Medicare prescription drug plans that covered 35.7 million Americans and found only a third of those with coverage could access "a painkilling skin patch that contains a less-risky opioid," whereas nearly all plans covered "common opioids, and very few required any prior approval." Further, they found that "insurers have also erected more hurdles to approving addiction treatments than for the addictive substances themselves."

And although addiction experts have observed that as this epidemic evolves, "the problem now appears to be rooted more in the illicit trade of heroin and fentanyl," the reporters also note a recent Centers for Disease Control and Prevention analysis showing that "risks for chronic use" increase "with each additional day" an opioid is prescribed, and of those patients who receive initial 10-day prescriptions, 20 percent will continue using the drugs after one year.

The ProPublica/Times report provoked an outpouring of personal anecdotes that often mirrored those featured in the article, and strong condemnation of insurance companies, as well as doctors and the pharmaceutical industry.

It also spurred calls for reform—to prescription practices and drug costs, but also to healthcare more broadly.

This report comes less than a week after Sen. Bernie Sanders (I-Vt.), with substantial support from Senate Democrats, introduced a bill aimed at reforming how Americans access health insurance and healthcare. Sanders' Medicare for All bill proposes transitioning from the U.S.'s for-profit healthcare system toward a national single-payer program that guarantees care for all Americans.

In an op-ed for the Boston Globe last week, Sen. Elizabeth Warren (D-Mass.) wrote of the opioid crisis: "I believe we can beat this epidemic," while also noting that overcoming the nationwide opioid crisis requires coordination and investment at all levels. Warren—who is co-sponsoring Sanders' healthcare bill— added:

Healthcare and social workers, counselors, and law enforcement agencies, and policy makers and administrators at the local, state, and federal levels of government are already putting it all on the line to help people overcome addiction. We must give them with the tools and support they need so we can win this fight.

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Senate Dems Help Torpedo Resolution That Would Have Blocked $650 Million Arms Sale to Saudi Arabia

"My simple question is, why in the world would the United States reward a regime that has caused such pain in Yemen with more weapons," Sanders asked after the vote. "The answer is we should not."

Brett Wilkins ·

Amnesty Scorecard Finds Twitter Failing to Protect Women From Online Abuse

"As our world has become increasingly dependent on digital spaces during the Covid-19 pandemic, it's critical that Twitter meet this moment with demonstrated commitment to improving the online experiences of all users, regardless of their identity."

Jessica Corbett ·

Filibuster Reform for Debt Ceiling Fight But Not Voting Rights or Reproductive Freedom?

"If our senators are willing to suspend the filibuster to protect our economy, they should be willing to suspend it to protect our democracy and our freedom to vote."

Jessica Corbett ·

As Senate Holds Guantánamo Hearing, Biden Urged to 'Finally End This Chapter of Injustice'

"Guantánamo is a centerpiece of the forever wars. It is a shameful symbol of racial injustice, torture, and violations of the Constitution and international law."

Brett Wilkins ·

'Unbreakable Solidarity': Kellogg's Workers Reject Contract That Would Leave New Employees Out of Benefits

"We're not willing to sell our souls for our future employees that are going to work side by side with us but not get the same pay or benefits."

Julia Conley ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.

Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo